Top Markets
Coin of the day
Brickell Biotech, Inc. Brickell Biotech, Inc.

Brickell Biotech, Inc.

BBI
Clasificación en acciones #40377
Brickell Biotech, Inc. is a pharmaceutical company currently in the clinical... Brickell Biotech, Inc. is a pharmaceutical company currently in the clinical development phase, dedicated to creating prescription medicines for various debilitating conditions, including autoimmune and inflammatory disorders, primarily within the United States. Its product pipeline includes sofpironium bromide, which has successfully finished Phase III clinical trials for treating excessive underarm sweating (primary axillary hyperhidrosis). Other notable candidates are BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent stimulator of interferon genes (STING) inhibitor, being explored for autoinflammatory and rare genetic illnesses. The company is also advancing next-generation kinase inhibitors. Brickell Biotech collaborates with several partners, such as Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. Established in 2009, its main office is located in Boulder, Colorado.
Precio por acción
$2.35
Última sincronización: 2022-09-07
Capitalización bursátil
$162.94K
Cambio (1 día)
2.17%
Cambio (1 año)
0.00%
País
US
Comercio Brickell Biotech, Inc. (BBI)

Categoría

Historial de desdoblamientos de acciones de Brickell Biotech, Inc. (BBI)
La acción Brickell Biotech, Inc. (símbolo: BBI) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 13, 2026.
Una acción BBI comprada antes de Aug 13, 2026 equivaldría hoy a 0 acciones BBI.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE